2018国际医药卫生导报Requires access

Clinical application value of serum pepsinogen I, II in the diagnosis and treatment of chronic atrophic gastritis

Huazhang Yan

Open publisher page 0 citations

Abstract

Objective To measure the serum levels of pepsinogen Ⅰ (PGⅠ), PGⅡ, and PGⅠ/PGⅡ ratio (PGR) in patients with chronic atrophic gastritis (AG), evaluate the value of these indicators in the diagnosis of chronic atrophic gastritis (AG). Methods Latex enhanced immunoturbidimetric was used to determine serum PGⅠ, PGⅡ, PGR levels of healthy control group (n=10), chronic non-atrophic gastritis (NAG) group (n=52), atrophic gastritis (AG) group (n=52) in Yangchun Hospital of Traditional Chinese Medicine from January 2016 to December 2017, and the value of these indicators in the diagnosis of chronic atrophic gastritis (AG) were evaluated. Results Serum PGⅠ, PGR levels in AG group were significantly lower than those in healthy control group, with statistically significant differences (P 0.05). Conclusion PGⅠ, PGⅡ, PGR joint detection has high diagnostic value in chronic atrophic gastritis. Key words: Pepsinogens; Serum; Atrophic gastritis; Diagnosis; Joint detection

About this research paper

What this paper is about

Objective To measure the serum levels of pepsinogen Ⅰ (PGⅠ), PGⅡ, and PGⅠ/PGⅡ ratio (PGR) in patients with chronic atrophic gastritis (AG), evaluate the value of these indicators in the diagnosis of chronic atrophic gastritis (AG). Methods Latex enhanced immunoturbidimetric was used to determine serum PGⅠ, PGⅡ, PGR levels of healthy control group (n=10), chronic non-atrophic gastritis (NAG) group (n=52), atrophic gastritis (AG) group (n=52) in Yangchun Hospital of Traditional Chinese Medicine from January 2016 to December 2017, and the value of these indicators in the diagnosis of chronic atrophic gastritis (AG) were evaluated. Results Serum PGⅠ, PGR levels in AG group were significantly lower than those in healthy control group, with statistically significant differences (P 0.05). Conclusion PGⅠ, PGⅡ, PGR joint detection has high diagnostic value in chronic atrophic gastritis. Key words: Pepsinogens; Serum; Atrophic gastritis; Diagnosis; Joint detection

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To measure the serum levels of pepsinogen Ⅰ (PGⅠ), PGⅡ, and PGⅠ/PGⅡ ratio (PGR) in patients with chronic atrophic gastritis (AG), evaluate the value of these indicators in the diagnosis of chronic atrophic gastritis (AG). Methods Latex enhanced immunoturbidimetric was used to determine serum PGⅠ, PGⅡ, PGR levels of healthy control group (n=10), chronic non-atrophic gastritis (NAG) group (n=52), atrophic gastritis (AG) group (n=52) in Yangchun Hospital of Traditional Chinese Medicine from January 2016 to December 2017, and the value of these indicators in the diagnosis of chronic atrophic gastritis (AG) were evaluated. Results Serum PGⅠ, PGR levels in AG group were significantly lower than those in healthy control group, with statistically significant differences (P 0.05). Conclusion PGⅠ, PGⅡ, PGR joint detection has high diagnostic value in chronic atrophic gastritis. Key words: Pepsinogens; Serum; Atrophic gastritis; Diagnosis; Joint detection

Key concepts: Atrophic gastritis, Gastroenterology, Internal medicine, Medicine, Pepsin, Gastritis, Helicobacter pylori, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical application value of serum pepsinogen I, II in the diagnosis and treatment of chronic atrophic gastritis — Research Paper | ScholarLens